Dr. Dawn Christopher, MD
NPI: 1265670046
Total Payments
$3,389
2024 Payments
$337.55
Companies
24
Transactions
102
Medicare Patients
4,777
Medicare Billing
$836,993
Payment Breakdown by Category
Food & Beverage$2,469 (72.9%)
Travel$894.69 (26.4%)
Education$24.74 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,469 | 96 | 72.9% |
| Travel and Lodging | $894.69 | 4 | 26.4% |
| Education | $24.74 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $1,174 | 9 | $0 (2019) |
| PFIZER INC. | $271.45 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $256.27 | 14 | $0 (2024) |
| Merck Sharp & Dohme LLC | $234.83 | 9 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $193.60 | 9 | $0 (2024) |
| BIOTRONIK INC. | $148.48 | 4 | $0 (2021) |
| Cardiovascular Systems Inc. | $129.00 | 1 | $0 (2018) |
| Zimmer Biomet Holdings, Inc. | $123.60 | 1 | $0 (2019) |
| Amgen Inc. | $108.94 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $108.75 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $337.55 | 17 | AstraZeneca Pharmaceuticals LP ($90.54) |
| 2023 | $665.41 | 33 | Novartis Pharmaceuticals Corporation ($102.40) |
| 2022 | $593.81 | 28 | Merck Sharp & Dohme LLC ($171.17) |
| 2021 | $365.06 | 13 | BIOTRONIK INC. ($148.48) |
| 2019 | $328.78 | 2 | Medtronic Vascular, Inc. ($205.18) |
| 2018 | $129.00 | 1 | Cardiovascular Systems Inc. ($129.00) |
| 2017 | $969.08 | 8 | Medtronic Vascular, Inc. ($969.08) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Cardiology | ||||||
| 08/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.83 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Respiratory | ||||||
| 04/24/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/12/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $29.74 | General |
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.67 | General |
| 02/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: DIABETES | ||||||
| 01/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/04/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/14/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2023 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/07/2023 | Ascensia Diabetes Care Us Inc. | — | Food and Beverage | In-kind items and services | $13.12 | General |
| 10/25/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Cardiology | ||||||
| 10/19/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,933 | 3,681 | $1.1M | $395,183 |
| 2022 | 25 | 1,725 | 2,631 | $741,914 | $275,218 |
| 2021 | 14 | 1,119 | 1,583 | $547,615 | $166,592 |
Total Patients
4,777
Total Services
7,895
Medicare Billing
$836,993
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 70 | 70 | $249,830 | $98,011 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 221 | 585 | $173,745 | $61,133 | 35.2% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 70 | 70 | $70,840 | $25,570 | 36.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 131 | 133 | $64,904 | $22,262 | 34.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 46 | 46 | $51,888 | $18,331 | 35.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 103 | 412 | $51,088 | $18,060 | 35.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 92 | 93 | $44,919 | $16,233 | 36.1% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 63 | 65 | $39,975 | $15,700 | 39.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 33 | 351 | $31,590 | $12,532 | 39.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 213 | 215 | $33,325 | $12,251 | 36.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 77 | 120 | $27,480 | $12,226 | 44.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 35 | 266 | $29,260 | $11,768 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $29,025 | $10,114 | 34.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 32 | 194 | $26,772 | $9,202 | 34.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 39 | 39 | $23,946 | $8,841 | 36.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 56 | $24,808 | $8,361 | 33.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 120 | 120 | $20,400 | $7,318 | 35.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 239 | 535 | $18,190 | $6,315 | 34.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 53 | 53 | $16,059 | $6,068 | 37.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 32 | 32 | $15,232 | $5,374 | 35.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 54 | $8,586 | $3,703 | 43.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 46 | 47 | $14,720 | $2,420 | 16.4% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 18 | 18 | $5,814 | $2,045 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $3,180 | $1,028 | 32.3% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 17 | 17 | $1,020 | $317.22 | 31.1% |
About Dr. Dawn Christopher, MD
Dr. Dawn Christopher, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Waldorf, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2009. The National Provider Identifier (NPI) number assigned to this provider is 1265670046.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dawn Christopher, MD has received a total of $3,389 in payments from pharmaceutical and medical device companies, with $337.55 received in 2024. These payments were reported across 102 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,469).
As a Medicare-enrolled provider, Christopher has provided services to 4,777 Medicare beneficiaries, totaling 7,895 services with total Medicare billing of $836,993. Data is available for 3 years (2021–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine, Internal Medicine
- Location Waldorf, MD
- Active Since 02/02/2009
- Last Updated 02/23/2017
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1265670046
Products in Payments
- ClosureFast (Device) $1,259
- VYNDAQEL (Drug) $210.41
- VERQUVO (Drug) $206.42
- LEQVIO (Drug) $183.52
- Peripheral Orbital Atherectomy System (Device) $129.00
- Dental Product Portfolio (Device) $123.60
- Repatha (Biological) $108.94
- JARDIANCE (Drug) $108.75
- Solia (Device) $99.44
- OPSUMIT (Drug) $97.12
- XARELTO (Drug) $93.17
- ENTRESTO (Drug) $72.75
- BRILINTA (Drug) $66.08
- ELIQUIS (Drug) $61.04
- Rybelsus (Drug) $54.21
- FARXIGA (Drug) $50.93
- Edora (Device) $49.04
- Kerendia (Drug) $41.59
- Barostim Neo System (Device) $41.54
- NEXLETOL (Drug) $34.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Waldorf
Anar Modi, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $801.83
Student in an Organized Health Care Education/Training Program $801.83
Beant Gill, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $745.55
Student in an Organized Health Care Education/Training Program $745.55
Rohit Patil
Student in an Organized Health Care Education/Training Program — Payments: $717.71
Student in an Organized Health Care Education/Training Program $717.71
Matthew Hockett, Od, OD
Student in an Organized Health Care Education/Training Program — Payments: $696.10
Student in an Organized Health Care Education/Training Program $696.10
Dr. Santina Burner, Od, OD
Student in an Organized Health Care Education/Training Program — Payments: $623.81
Student in an Organized Health Care Education/Training Program $623.81
Konika Sharma, Mbbs, MBBS
Student in an Organized Health Care Education/Training Program — Payments: $377.54
Student in an Organized Health Care Education/Training Program $377.54